AB8939

· AB Science

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB8939, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]